Immix Biopharma Inc (IMMX)

Nov 10, 2024

Private Advisor Group LLC Has $51,000 Stake in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Nov 10, 2024

Oct 12, 2024

Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Oct 12, 2024

Oct 06, 2024

Immix and Nexcella Make Progress in US Trial for Light Chain Amyloidosis CAR-T NXC-201 - CGTLive™

Oct 06, 2024

Oct 04, 2024

Immix BiopharmaUS CAR-T trial progresses to dose expansion - Smartkarma

Oct 04, 2024

Oct 03, 2024

H.C. Wainwright confident in Immix stock growth with progress in NEXICART-2 CAR-T trial - Investing.com

Oct 03, 2024

Oct 03, 2024

Immix Biopharma’s (IMMX) “Buy” Rating Reiterated at HC Wainwright - Defense World

Oct 03, 2024

Oct 03, 2024

XTX Topco Ltd Sells 34,534 Shares of Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Oct 03, 2024

Oct 02, 2024

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort - GlobeNewswire

Oct 02, 2024

Oct 02, 2024

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2 - StockTitan

Oct 02, 2024

Oct 01, 2024

Immix Biopharma stock hits 52-week low at $1.51 amid market challenges - Investing.com Australia

Oct 01, 2024

Sep 23, 2024

Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down - MSN

Sep 23, 2024

Sep 21, 2024

Immix Biopharma stock hits 52-week low at $1.74 amid market challenges - Investing.com Australia

Sep 21, 2024

Sep 19, 2024

Immix Biopharma Announces Dr. Raymond Comenzo, - GlobeNewswire

Sep 19, 2024

Sep 19, 2024

Immix Biopharma gains AL Amyloidosis expert for advisory board - Investing.com

Sep 19, 2024

Sep 19, 2024

Immix Biopharma gains AL Amyloidosis expert for advisory board By Investing.com - Investing.com Australia

Sep 19, 2024

Sep 19, 2024

Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board - StockTitan

Sep 19, 2024

Sep 14, 2024

Immix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Update - MarketBeat

Sep 14, 2024

Sep 02, 2024

It would be worthwhile to take a closer look at Immix Biopharma Inc (IMMX) - US Post News

Sep 02, 2024

Sep 02, 2024

Its Stock Has Paid Off Big Time For Immix Biopharma Inc - SETE News

Sep 02, 2024

Sep 02, 2024

The Attractiveness of Investing In Immix Biopharma Inc (IMMX) is Growing - Knox Daily

Sep 02, 2024

Aug 29, 2024

Immix Biopharma Independent Director Acquires 2.6% More Stock - Yahoo Finance UK

Aug 29, 2024

Aug 29, 2024

Insider Spends US$52k Buying More Shares In Immix Biopharma - Simply Wall St

Aug 29, 2024

Aug 28, 2024

Immix Biopharma expands clinical trial sites for AL Amyloidosis therapy - Investing.com

Aug 28, 2024

Aug 28, 2024

Immix Biopharma expands clinical trial sites for AL Amyloidosis therapy By Investing.com - Investing.com Canada

Aug 28, 2024

Aug 28, 2024

Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2 - GlobeNewswire

Aug 28, 2024

Aug 28, 2024

The markets will rise or fall with NVDA - RagingBull

Aug 28, 2024

Aug 26, 2024

Immix Biopharma director Jason Hsu buys $51,623 in company stock - Investing.com

Aug 26, 2024

Aug 22, 2024

Best Biotech Stocks Right Now • Updated Daily - Benzinga

Aug 22, 2024

Aug 21, 2024

Immix Biopharma Inc’s latest rating changes from various analysts - Knox Daily

Aug 21, 2024

Aug 21, 2024

Q3 2024 Earnings Estimate for Immix Biopharma, Inc. Issued By HC Wainwright (NASDAQ:IMMX) - MarketBeat

Aug 21, 2024

Aug 21, 2024

HC Wainwright Weighs in on Immix Biopharma, Inc.’s Q3 2024 Earnings (NASDAQ:IMMX) - Defense World

Aug 21, 2024

Aug 20, 2024

Immix Biopharma, Inc. (NASDAQ:IMMX) Director Carey Ng Purchases 10,000 Shares of Stock - Defense World

Aug 20, 2024

Aug 19, 2024

Immix Biopharma, Inc. (NASDAQ:IMMX) Director Purchases $18,600.00 in Stock - MarketBeat

Aug 19, 2024

Aug 19, 2024

Immix Biopharma, Inc. to Post FY2024 Earnings of ($0.61) Per Share, Edison Inv. Res Forecasts (NASDAQ:IMMX) - MarketBeat

Aug 19, 2024

Aug 19, 2024

Immix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Down 7.5% in July - MarketBeat

Aug 19, 2024

Aug 19, 2024

What Makes Immix Biopharma (IMMX) a New Buy Stock - MSN

Aug 19, 2024

Aug 19, 2024

Immix Biopharma (NASDAQ:IMMX) Rating Reiterated by HC Wainwright - MarketBeat

Aug 19, 2024

Aug 19, 2024

HC Wainwright Reaffirms Buy Rating for Immix Biopharma (NASDAQ:IMMX) - Defense World

Aug 19, 2024

Aug 19, 2024

FY2024 Earnings Forecast for Immix Biopharma, Inc. (NASDAQ:IMMX) Issued By Edison Inv. Res - Defense World

Aug 19, 2024

Aug 12, 2024

IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024 - InvestorPlace

Aug 12, 2024

Aug 12, 2024

Immix Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Aug 12, 2024

Aug 12, 2024

Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely? - Simply Wall St

Aug 12, 2024

Aug 05, 2024

Monitoring Immix Biopharma Inc (IMMX) after recent insider movements - Knox Daily

Aug 05, 2024

Aug 02, 2024

Jason Hsu Purchases 6,000 Shares of Immix Biopharma, Inc. (NASDAQ:IMMX) Stock - Defense World

Aug 02, 2024

Aug 01, 2024

Umoja Biopharma's In Situ CAR-T Therapy Cleared for US Trial in Hematologic Malignancies - CGTLive™

Aug 01, 2024

Jul 31, 2024

Immix Biopharma director Jason Hsu buys $19.5k in company shares - Investing.com

Jul 31, 2024